Earnings Feed
Sign Up
Home/Filings/4/0001144204-12-051753
4//SEC Filing

TRANSGENOMIC INC 4

Accession 0001144204-12-051753

$PRPOCIK 0001043961operating
View on SEC.govCompany Profile

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 5:13 PM ET

Size

9.9 KB

Accession

0001144204-12-051753

Insider Transaction Report

Form 4
Period: 2012-09-12
TRANSGENOMIC INCTBIO.OB
COLONNESE MARK P
Chief Financial Officer
Transactions
  • Award

    Purchase Option

    2012-09-12+83,333→ 83,333 total
    Exercise: $0.98From: 2014-10-01Exp: 2022-09-11→ Common Stock (83,333 underlying)
  • Award

    Purchase Option

    2012-09-12+83,334→ 83,334 total
    Exercise: $0.98From: 2013-10-01Exp: 2022-09-11→ Common Stock (83,334 underlying)
  • Award

    Purchase Option

    2012-09-12+83,333→ 83,333 total
    Exercise: $0.98From: 2015-10-01Exp: 2022-09-11→ Common Stock (83,333 underlying)
Footnotes (2)
  • [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
  • [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 250,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.

Documents

1 file

Issuer

TRANSGENOMIC INC

CIK 0001043961

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001043961

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:13 PM ET
Size
9.9 KB
View on SEC.gov